Home >> Report Store >> Healthcare >> Cholera Vaccines Market Report >

Cholera Vaccines Market Size Worth $1.36 Billion By 2025 | CAGR: 10.3%

Published Date : 27 / 09 / 17 | Report Format: PDF

The global Cholera Vaccines market is expected to grow at the growth rate of 10.3% to reach USD 1,367.8 million by 2025.

As per the World Health Organization (WHO), approximately 172 454 cholera cased were reported from a total of 42 countries in 2015 and this number is projected to increase during the coming years. Similarly, the Health for Life Foundation stated that more than 4 million cholera cases are registered every year and it causes around 30,000 to 142,000 deaths yearly across the globe. Thereby, the rising number of people affected with cholera is one of the potential driver for the market growth. Furthermore, the growth of this market is supported by increasing research and development activities, a growing number of companies investing in this industry coupled with strong clinical pipelines. For instance, PaxVax, Inc. has a pediatric cholera vaccine in phase IV clinical study that is expected to approve shortly by the U.S. FDA. Further, in June 2016, the company received regulatory approval for Vaxchora, PaxVax, Inc.’s single-dose oral cholera vaccine. This product was the only available vaccine indicated for the protection against cholera in the U.S. Such approvals would, in turn, augment the market growth significantly. However, high treatment cost will pull back the market growth to some extent. For instance, as per the various research studies, cost of protection against conditions such as cholera is more than USD 7 per fully immunized person. Of these, 90% of the cost is for the vaccination.

Key Takeaways:

  • Based on different products, Dukoral and Shanchol accounted for the majority share of the global revenue. In 2017, over 80% revenue share was captured by these two products collectively.
  • Dukoral is a monovalent inactivated vaccine, composed of Killed whole-cells of V. cholerae O1 and recombinant B-subunit of cholera toxin. This vaccine is manufactured by SBL Vaccin AB, Sweden and Crucell, Leiden, The Netherlands
  • Dukoral was the first oral cholera vaccine to get approval in the European Union (EU) during the year 2004
  • Whereas, Shanchol is a bivalent inactivated vaccine, composed of Killed whole cells of V. cholerae O1 and V. cholerae O139. This vaccine is developed by Shantha Biotechnics (India) and Sanofi
  • Regionally, the demand for cholera vaccine is anticipated to increase in regions such as Africa, Asia and some part of America. According to the World Health Organization data (2014), there were around 55%, 30% and 15% increase in cholera cases in regions such as Africa, Asia, and America respectively.
  • Companies namely Pfizer, Inc., Merck & Co., GlaxoSmithKline, Sanofi, and Novartis are actively operating in this industry.


  • The report presents a macro and micro-level outlook regarding the industry. Thus, it becomes easy for our clients to perceive the business landscape and take a glimpse of their own standing in it.
  • A thorough analysis of relevant statistical data to estimate the market paradigms
  • Exceptional understanding of the region and country-specific markets. The report will answer some of the toughest questions regarding the market shares, sizes, forecasts segmentation, and growth specific to the countries.
  • Well-designed strategic framework analyzes the market movements including regional expansion, mergers & acquisitions, and new product developments

The scope of this report covers the market by its major segments, which include as follows:

Market Segmentation


  • Dukoral
  • Shanchol
  • Vaxchora
  • Others


  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • France
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Rest of APAC
  • Rest of the World
    • Middle East and Africa
    • Latin America

Why AnalystView



Trusted Partnership

We strive to become one of the trusted partner of our client by offering value added services and concrete research data.


Tailor Made Solutions

From single reports and data downloads to enterprise subscriptions to custom consultancy, we can base our precise solutions round our client’s exact needs.

Turnaround Time

Our analyst aims to provide research studies in quickest turnaround time and in a much cost effective manner.


Data Accuracy And Reliablity

We utilize a mix of primary, secondary research, and machine learning algorithms to generate accurate and comprehensive data about market size and revenue forecasts.

Competitive Pricing

We offer most competitive pricing policy across the research industry

Client Testimonials


Asia Pacific based Chemical Industry (Privacy Requested)

Thanks AnalystView for putting a great team to work on our research projects. It was a smooth transition of knowledge and delivery was seamless. We are keen to work with you on our upcoming projects. Thank you once again for the professional attitude your team has demonstrated.

CEO, Europe based Digital Media Company (Privacy Requested)

We had confusion after receiving the final data sheet of report. As per some preliminary we already have, we believe the market is over estimated.. However, after string of calls with analyst, we found their final research analysis was methodologically sound and their work to be very professional and up […]

Managing Director, Chemical based Company, Asia Pacific (Privacy Requested)

We are happy with the way the AnalystView member understood the brief and went about executing our research project.

U.S. Headquartered Medical Device Company (Privacy Requested)

AnalystView team has done brand assessment study for blood glucose monitoring devices market, in which we want enter into….We were very impressed not only by their research skills but also by their understanding of issues relevant to our requirements…!!

Vice President, Petrochemical Firm based in China (Privacy Requested)

It was a pleasure assigning project to AnalystView; they are reliable, fast and friendly. Highly recommend this company for research workJGood stuff!

US based healthcare service provider (Privacy Requested)

Frankly, we didn’t expect much comprehensive data for the report we purchased. To be surprised, I must say the report we received was very nicely executed….It contains all the information we are looking for and satisfied with the quality of the report. Thank you team

Europe based Chemical Industry (Privacy Requested)

Just wanted to say massive thanks for all the help from the AnalystView team. We purchased two reports one is Food Safety Testing report and another one is Enzyme market. These reports have helped us build a sound knowledge base of our business segments and have taken our business to […]

Why Choose Us


We devise research report with quality data:

Combined with an in-depth knowledge of the current industry and a sharp analytical mind, AnalystView serve our customer accurate research in accordance with a constantly evolving industry.

We work with businesses just like yours: 

AnalystView committed to making a positive difference for our clients. This means whatever you demand, chances are we already have experience with something similar.

Share This